©The Author(s) 2019.
World J Gastroenterol. Feb 7, 2019; 25(5): 622-631
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.622
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.622
Table 2 Patients’ baseline characteristics
| Characteristic | Value |
| Clinical information | |
| Age (yr) | 50.31 ± 10.87 (range: 26-77) |
| Male/female | 157/46 |
| Etiology of liver disease | |
| Hepatitis B virus | 194 (95.57%) |
| Hepatitis C virus | 8 (3.94%) |
| Both hepatitis B and C virus | 1 (0.49%) |
| Tumor size (cm) | Median 5.3 (range: 1.1-12.8) |
| AFP level (ng/mL) | 102.3 ng/mL (range 1.2-15926.0) |
| Serum AST (≥ 35 IU/L) | 107 (52.7%) |
| Serum ALT (≥ 40 IU/L) | 82 (40.4%) |
- Citation: Zhang T, Huang ZX, Wei Y, Jiang HY, Chen J, Liu XJ, Cao LK, Duan T, He XP, Xia CC, Song B. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? World J Gastroenterol 2019; 25(5): 622-631
- URL: https://www.wjgnet.com/1007-9327/full/v25/i5/622.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i5.622